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Abstract
Background: Video gaming is a promising intervention for cognitive and social impairment in patients with
schizophrenia. A number of gaming interventions have been evaluated in small-scale studies with various patient
groups, but studies on patients with schizophrenia remain scarce and rarely include the evaluation of both clinical
and neurocognitive outcomes. In this study, we will test the effectiveness of two interventions with gaming
elements to improve cognitive and clinical outcomes among persons with schizophrenia.
Methods: The participants will be recruited from different outpatient units (e.g., outpatient psychiatric units, day
hospitals, residential care homes). The controlled clinical trial will follow a three-arm parallel-group design: 1)
cognitive training (experimental group, CogniFit), 2) entertainment gaming (active control group, SIMS 4), and 3)
treatment as usual. The primary outcomes are working memory function at 3-month and 6-month follow-ups. The
secondary outcomes are patients’ other cognitive and social functioning, the ability to experience pleasure, self-
efficacy, and negative symptoms at 3-month and 6-month follow-ups. We will also test the effectiveness of gaming
interventions on neurocognitive outcomes (EEG and 3 T MRI plus rs-fMRI) at a 3-month follow-up as an additional
secondary outcome. Data will be collected in outpatient psychiatric services in Hong Kong. Participants will have a
formal diagnosis of schizophrenia and be between 18 and 60 years old. We aim to have a total of 234 participants,
randomly allocated to the three arms. A sub-sample of patients (N = 150) will be recruited to undergo an EEG. For
neuroimaging assessment, patients will be randomly allocated to a subset of patients (N=126). We will estimate the
efficacy of the interventions on the primary and secondary outcomes based on the intention-to-treat principle.
Behavioural and EEG data will be analysed separately.
Discussion: The study will characterise benefits of gaming on patients’ health and well-being, and contribute
towards the development of new treatment approaches for patients with schizophrenia.
Trial registration: ClinicalTrials.gov NCT03133143. Registered on April 28, 2017.
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Background
More than 21 million people worldwide suffer from
schizophrenia [1]. Schizophrenia is associated with se-
vere disabilities in cognition and global functioning [2,
3]. Deficits in attention, executive function and working
memory are the core challenges for this patient group
[4, 5]. Having a working memory is a crucial part of
daily functioning and holding and manipulating informa-
tion [6]. Poor working memory is associated with poor
functional outcome [4] and limits for social relationships
[7]. Disabling cognitive symptoms in schizophrenia are
associated with prefrontal dysfunction [8].
Cognitive deficits can be improved with specialised
cognitive training programmes. For example, remedi-
ation therapy is designed to improve attention, memory,
and problem solving [9]. Various types of computer-
based applications for cognitive remediation have also
been established, as well as serious games, which are
specialised for training cognitive deficits. Fisher et al.
tested a set of computerised exercises in patients with
schizophrenia and showed that those who made the
most progress in the basic psychophysical auditory exer-
cise also exhibited the most improvement in verbal
working memory and global cognition [10]. More re-
cently, video gaming in general (on a computer, console,
online platform, or mobile device) and sole entertain-
ment games (action, sport, role-playing, adventure, fight-
ing, racing, family entertainment, casual games) [11]
have opened up an avenue for new remedial interven-
tions targeting attention, problem-solving, emotional ex-
pression, and socialization [12]. This approach is
potentially more effective than direct instructional
methods, such as coaching, which yields limited benefits
for patients with schizophrenia [13]. Kühn et al., for ex-
ample, reported that video gaming increases grey matter
volume in the brains of healthy adults, and they recom-
mended gaming for patients with schizophrenia [14].
Functional magnetic resonance imaging (fMRI) studies
have recently been used in working memory tests for pa-
tients with schizophrenia [15]. Some studies have re-
ported increased activation of the dorsolateral prefrontal
cortex (DLPFC) in patients with schizophrenia during
their working memory performance [16]. Imaging
methods have also been used to assess the effectiveness
of gaming interventions for neurocognitive outcomes.
One fMRI study suggested that persons who have played
a shooter game improved their attentional resources
more efficiently than non-gamers [17]. A systematic re-
view further suggests action video games as a promising
method in mental health treatment, as asserting that
specific types of video games can alter brain structure or
improve certain aspects of cognitive functioning [18].
Video gaming may be particularly useful for persons
who have difficulties in treatment compliance or
engagement because gaming itself may offer positive ex-
periences and emotions [19, 20], a sense of self-efficacy,
relatedness, and social interaction [21, 22]. These effects
are expected to benefit patients with schizophrenia [2–
5]. Further, video gaming is cost effective and allows
personalised targeting of specific brain abnormalities by
ameliorating the dysfunction in specific brain circuits
and normalizing network dynamics. When suitably
scaled, gaming may be highly effective in countering the
impact of risk factors associated with prodromal states
of various mental disorders [14, 22]. This suggestion is
in keeping with speculation that some commercially
available video games may already have the potential to
cause changes in human behaviour [23]. However, the
influences of video gaming on brain function and struc-
tures, in relation to its potential benefits for cognitive
functioning, social relationships [18], pleasure and self-
efficacy, remains poorly characterised [13]. In addition,
the most useful setting for the implementation of gam-
ing interventions is still unclear [24].
We hypothesise that playing video games [13] may
alter brain function, cognition and behaviour [23] for
patients with schizophrenia [25]. Benefits for prospective
memory impairments and emotion-behaviour decoup-
ling related hedonia have been demonstrated in schizo-
phrenia patients [26]. One neuroimaging study outside
of the field of mental health shows that both early stimu-
lus processing and late retention period activities associ-
ated with video gaming could improve visual working
memory function, and suggests that video gaming might
be suitable for patients with schizophrenia [27]. Indeed,
there is some evidence that entertainment games can be
useful in mental health in, for example, improving
moods or stress levels [28, 29]. However, these are stud-
ies with small sample sizes and narrow scopes in age
groups [30].
Based on the current role of video gaming [10], its
rapid expansion in the market, and its promises in treat-
ment for persons with schizophrenia, it is important to
conduct a larger-scale investigation to fully characterise
its potential clinical profile and efficacy [30]. Here, we
will test the effectiveness of gaming embedded within
two interventions in a longitudinal study on relevant
cognitive and clinical outcomes, as well as EEG and neu-
roimaging assessments (structural MRI, resting-state




This study aims to compare the effectiveness of cogni-
tive training using computerized gaming exercises to
that of entertainment video gaming and a non-gaming,
passive control group, looking at a range of outcomes.
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The primary objective is to test the effects of the inter-
ventions on patients’ cognition, especially on working
memory at 3-month and 6-month follow-ups. The sec-
ondary objectives are to test the effects of the interven-
tions on patients’ other cognitive and social functioning,
the ability to experience pleasure, self-efficacy, and nega-
tive symptoms at 3-month and 6-month follow-ups.
Additional secondary outcomes are EEG brain activity




1. Cognitive training with computerised exercises is
more effective than entertainment video gaming or
the non-gaming control in improving patients’
working memory at a 3-month and/or 6-month
follow-up.
Secondary hypotheses:
2. Cognitive training with computerised exercises is
more effective than entertainment video gaming
and the non-gaming control in improving patients’
cognitive and social functioning, experience of
pleasure, and self-efficacy at a 3-month and/or 6-
month follow-up.
3. Cognitive training with computerised exercises is
more effective than entertainment video gaming
and the non-gaming control in improving negative
symptoms in schizophrenia at a 3-month and/or 6-
month follow-up.
4. Cognitive training with computerised exercises is
more effective than entertainment video gaming
and the non-gaming control in improving neuro-
cognitive outcomes (EEG signals, brain activity and
structure) at a 3-month follow-up.
Trial design
The effectiveness of the intervention will be assessed
using a controlled clinical trial with a pragmatic, three-
arm parallel-group design. The three-arm design is
chosen to explicitly test the superiority of the experi-
mental cognitive training with computerised exercises
(CogniFit) compared to the active control (entertain-
ment games) and treatment as usual (non-gaming pas-
sive control) [31]. Since the objective of the study is to
test the efficacy of the type of gaming (cognitive training
with computerised exercises vs. entertainment gaming),
having a three-arm trial is necessary to assess the effects
of the gaming types separately.
To assess fidelity, we will use gaming diaries to verify
whether the interventions have been delivered as intended
(intervention fidelity) and confirm patient gaming activity
(gaming frequency [number of gaming sessions per week],
the length of each session [minutes], number of drop-
outs). We will also analyse any information on the per-
ceived strengths and limitations of interventions written
in the patients’ diaries.
Study setting and participant characteristics
The data collection, subject recruitment and gaming will
be carried out in outpatient services (e.g., outpatient psy-
chiatric units, day hospitals, residential care homes). Spe-
cific inclusion criteria mandate that patients should have a
formal diagnosis of schizophrenia spectrum disorder (Diag-
nostic and Statistical Manual of Mental Disorders, fifth edi-
tion, DSM-5), and be between 18 and 60 years old. We will
intentionally recruit people who are non-active, less-
experienced gamers [19]. Participants will be required to
be able to speak Cantonese, be able to participate based on
their own free will and have the ability to provide written
informed consent. Participants should have a cognitive sta-
tus deemed suitable for study participation based on ‘the
judgement standard’, i.e., be approved by the staff respon-
sible of the treatment based on their clinical expertise.
The exclusion criteria are: 1) meeting the diagnostic
criteria for a current major depressive, manic or hypo-
manic episode (DSM-5), or mental retardation, 2) having
severe visual impairment, 3) being an active gamer (i.e.
gaming > 5 h/week [17]), 4) displaying a lack of ability to
decide one’s own participation, 5) substance abuse (other
than nicotine dependence), 6) head injury, hemiplegia,
or other neurological disorder, 7) electroconvulsive ther-
apy (ECT) in the past six months, 8) having a lack of
Magnetic Resonance Imaging (MRI) compatibility (e.g.,
cardiac pacemakers, metallic implants, restless behav-
iour, claustrophobia), and 9) pregnancy.
Power analysis and sample size
We have calculated the sample size based on the
primary outcome as follows: (1) the number of actual
pairwise tests to be made for the efficacy of the primary
outcome and (2) the two-level modelling approach in
the final data analysis, in which the type I error has been
adjusted. The statistical efficiency will be ensured using
the multivariate analysis of variance (MANOVA)
method for multiple group comparison. First, given that
video gaming is a fairly novel strategy, we will base the
sample size calculation (a priori) [32] on a cognitive-
efficacy meta-analysis for patients with schizophrenia
[33] showing an overall effect size (ES, Cohen’s d) of
0.58 on verbal working memory (a primary outcome).
Based on our hypothesis, the primary endpoints will be
the effects on verbal working memory after 3 and 6
months of cognitive training group (CogniFit), compared
with the other two groups: cognitive training vs.
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entertainment gaming, cognitive training vs. non-gaming
control group, and entertainment gaming vs. non-
gaming control group. Four pairwise interactions be-
tween the contrast of the two comparisons and the two
time points will be tested. For multiple comparison tests
of four, for a type I error level of 5% (two-sided), an ad-
justed significant level should be α/2 = (1- (1–0.05)4) /2
= 0.01274 /2 = 0.0064, and the corresponding z score for
a one-tailed test should be 2.49. Given the effect size
0.58, assuming equal sample size of the three groups,
with a statistical power of 0.8 and α= 0.01274, we will
require at least 198 subjects (66 per group at follow-up
phase) by applying the equation, 2(Z1-β + Z1-α/2)2 /
ES2. According to a meta-analysis [33], the total sample
size in previous cognitive training studies was around 50
(range 10–138).
Using evidence-based rationale for patient flow in this
study, we can assume that about 60% of patients
screened will not be eligible for the study, due to age or
lack of capacity to participate in the study [34]. Based on
existing literature, we anticipate that about 45% of pa-
tients with schizophrenia will refuse to participate in the
RCT studies [33], about 60% of patients screened will
not be eligible for the study, and around 16% will drop
out during the course of intervention [35]. Thus, we
need a total of 1073 subjects to be approached and 237
participants to be randomly allocated to three study
groups (79 patients/group) to ensure a final sample of
198 participants in the follow-ups (66 patients/group).
These numbers are realistic given that the total number
of patients with schizophrenia in our study sites is about
5500, and the total number of schizophrenia patients in
Hong Kong is 40,000.
For the EEG analysis, a sub-sample of 50 patients in
each group will be recruited (N = 150). For neuroimag-
ing assessment using 3 T MRI and rs-fMRI, a sub-
sample of 126 participants from our total sample (N =
198) will need (63%) to be randomised at baseline.
Randomisation will be based on a list of computer-
generated random numbers. We assume that 30% will
drop-out between baseline and the 3-month follow-up
assessment, which leaves us with 29 patients in each
group (a total of 87 participants at baseline). The sample
size will be appropriate for our neuroimaging assess-
ment; the average number of participants in RCT studies
assessing patient cognition [33] or changes in brain
structure has been about 20 [14]. The flow-chart of the
study is presented in Fig. 1.
Recruitment
For privacy purposes, the medical records in each service
organisation will be screened by the clinical staff to de-
termine the eligibility of patients to participate in the
study. To ensure that patients have the capacity to make
the decision to participate or not, an extended informed
consent process will be used [36]. Eligible participants
will first receive a short leaflet about the study from the
staff or during a short information session organised for
the participants to consider their availability. If an eli-
gible patient shows interest, more detailed written and
oral information will be given. It will be ensured that a
patient understands the information and they will have
the opportunity to ask any questions. If a patient is will-
ing to participate in the study, they will sign an informed
consent form. To ensure accuracy of the written infor-
mation to be provided to subjects, its content will be
revised whenever new information relevant to the sub-
ject’s consent becomes available. Prior to participation in
the trial, the study participants will receive a copy of the
signed and dated written informed consent form and
any other written information provided to the subjects.
If any updates occur, the participant will receive a copy
of the signed and dated consent form updates and a
copy of any amendments to the written information pro-
vided to subjects during their participation in the trial.
After signing the informed consent form, background
information of each respondent, their Intelligence
Quotient (IQ, if available in medical records) and Mini
Mental State Examination (MMSE) will be collected [37].
Their medication dosages (chlorpromazine equivalence)
will also be collected as medications currently used in
schizophrenia may affect the response to cognitive train-
ing strategies [9, 37]. A simple practical test to assess the
participants’ computer skills will be carried out (starting
up a computer, using a mouse). If any doubts of computer
use arise, our intervention is long enough (12 weeks) for
participants to learn basic computer and gaming skills.
The recruitment will end as soon as the planned total
numbers of participants are reached for the analysis.
Randomisation, allocation concealment and blinding
(masking)
After baseline data collection, the trial manager will be
notified of new participants. Each participant will be al-
located to one of the three arms based on a list of
computer-generated random numbers provided by an
external clinical trial randomisation service (blocks of 6
consecutive patients, a 1:1:1 ratio). Allocation will be
masked to the trial statistician, but it cannot be masked
to the research assistants (RAs) who will supervise the
gaming sessions and collect follow-up outcome data, or
from the study unit staff who will work with the pa-
tients. Furthermore, a sub-sample of 150 participants
will be recruited for EEG analysis, and 126 participants
from our total sample will be randomly selected and
assigned to neuroimaging assessment at baseline (fMRI).
Again, the participants for neuroimaging assessment will
be allocated based on a separate list of computer-
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generated random numbers provided by an external
clinical trial randomisation service (blocks of 6 consecu-
tive patients, a 1:1:1 ratio). The trial manager will inform
the RAs the identities of participants allocated to fMRI
assessment.
Interventions
Participants will be allocated into three groups: 1) cognitive
training with computerised exercises (G1, CogniFit, N=78),
2) entertainment video gaming (G2, Entertainment Gam-
ing, N=78), and 3) treatment as usual (N=78). CogniFit and
entertainment games (SIMS 4) represent two distinct gam-
ing genres: CogniFit is a cognitive training package with
computerised exercises aiming to improve cognitive abil-
ities based on a personalised brain training regimen. SIMS
4 is a pure entertainment game without any known health
impact. The administration of both interventions will in-
clude 60 pre-scheduled gaming sessions [38] at the study
settings as part of the normal day programme, lasting from
45 to 60min each, at least 5 days/week [17], 60 h in total.
The gaming schedule can also be tailored based on the par-
ticipants’ needs (working, studying, family issues) as long as
the gaming hours are in line with the total hours planned.
Individual gaming sessions on separate computers will be
conducted in small groups (about 3–6 per group) and
closely monitored by the trained research assistant. Moni-
toring of gaming sessions is crucial to ensure intervention
fidelity. This was exemplified in our feasibility study, which
showed that, out of all possible 60 pre-scheduled sessions,
97% of sessions were realised as planned, and all partici-
pants enjoyed gaming. Gaming hours (diaries, automatic
gaming logs) for each gaming session will be recorded to
provide evidence of the intervention fidelity; a minimum of
50 gaming hours will be acquired to ensure observable neu-
roplasticity after gaming [19]. To report any negative side
effects of gaming (e.g., tiredness of eyes), feedback and any
concerns will be reported in a gaming diary after each gam-
ing session [39].
Fig. 1 Flow chart of the GAME-S study
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Cognitive training with computerised exercises (an
experimental intervention group, CogniFit)
The supposed mechanism of CogniFit is derived from
evidence that computerised exercises focusing on
auditory and verbal processing are likely to yield im-
proved verbal learning and memory [12], and activate
the brain reward system that drives brain plasticity in
adults with schizophrenia [40, 41]. Exercises include
the elements needed for an effective cognitive inter-
vention: a large number of specific repetitive learning
trials driven by maximally enduring, neurologically re-
liable cognitive gains, and individually adapted con-
tent based on each learner’s needs [12]. To match the
training regimen for each participant’s unique cogni-
tive needs (deficits), a short assessment using Cogni-
Fit exercises will be done at the beginning of the
intervention. During each training session, the partici-
pants will be instructed to play memory games and at
least one exercise from each of the three categories:
memory, spatial perception, and mental planning.
Otherwise, they will be free to choose which exercises
they wish to play.
During the first gaming session, a game will be intro-
duced to the participant, and its use will be tested to-
gether with an RA. The participant’s ability to play
digital games will be explored to ensure that they have
the basic gaming skills required for active gaming (how
to start the computer, how to play the game, how to
change game options, and so on). During each gaming
session, an RA will be available for gaming support. The
RA will also provide assistance, if required, based on
each gamer’s individual needs.
Entertainment video gaming (an active control group)
The video game offers entertainment without any
known cognitive or health-related outcome. We will
use SIMS 4, which includes a variety of personalities
portrayed as cartoon characters that be customised
based on gamers’ needs and wishes. For example, a
gamer can change the clothing of characters, develop
their stories, build homes, have the characters travel
and build relationships between characters. As in the
intervention group, an RA will be available during
each gaming session to guide and support gaming
skills and initiatives.
Treatment as usual (a passive control group)
No specific gaming intervention will be offered to those
who receive treatment as usual. To minimise the risk of
intervention contamination, the participants will be en-
couraged not to play video games during the study
period and will be asked to report any video gaming with
which they may have engaged.
Outcome evaluation (primary and secondary outcomes)
Primary outcome
Verbal working memory will be measured with the
Letter-Number-Sequencing task (Letter-Number-Span-
Test, LNST) from WMS III (Wechsler Memory Scale,
the 3rd Edition, simplified/traditional Chinese versions).
The instrument includes an NIMH-MATRICS (US
National of Institute of Mental Health, the Measurement
and Treatment Research to Improve Cognition in
Schizophrenia) battery [42].
Secondary outcomes
Cognitive functioning A battery of cognitive tests will
be used to measure the processing speed [Trail Making
Test, TMT, A [42]], attention and vigilance [Sustained
Attention to Response Task, SART], visuospatial work-
ing memory [Spatial Span from WMS III [42]], and rea-
soning and problem solving [Wisconsin Card Sorting
Test [42]]. The instruments to be used are well tested,
reliable, recommended, and available in simplified/trad-
itional Chinese, either in paper or digital format [42].
Social functioning A Chinese version of the Brief Social
Phobia Scale, BSPS, will be used for assessing the sever-
ity of and treatment response to social phobia [43]. The
Cronbach’s alpha for the Chinese version is 0.88, which
states a high level of internal consistency [43].
Experience of pleasure The Temporal Experience of
Pleasure Scale (TEPS, Chinese version) covers anticipa-
tory and consummatory components (Cronbach’s
alpha=0.83; test-retest reliability r=0.79) [44].
Self-efficacy The Chinese version of the General Self-
Efficacy Scale, GSE, a self-reporting measurement of
self-efficacy with good internal consistency (Cronbach’s
alpha = 0.91), will be used [45].
Negative symptoms of schizophrenia The Chinese ver-
sion of the Clinical Assessment Interview for Negative
Symptoms (CAINS) [46] will be administered by quali-
fied psychiatrists who have received proper training for
this assessment tool. The item-total score correlation
will also be presented for each item, and can range from
0.58 to 0.81. The internal consistency (Cronbach’s alpha)
for the scale is high (0.91) [46].
Other Depressive symptoms will be measured with the
Calgary Depression Scale for Schizophrenia (CDS-C)
[47], an observer-rated Likert-scale to measure depres-
sive symptoms (Cronbach’s alpha=0.80; inter-rater
reliability Kappa coefficient > 0.79; test-retest reliability
r=0.927), the Simpson-Angus Rating Scale (SAS) [48],
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the Barnes Akathisia Rating Scale (BARS), and the
Abnormal Involuntary Movement Scale (AIMS). Par-
ticipants’ IQs will be collected from medical records
(if available) and the Mini-MMSE will be used to ver-
ify each participant’s capacity to participate in the
study. If, at baseline, it is obvious that the participant
suffers from a condition that will interfere with par-
ticipation in the study (IQ, MMSE), the participant
will be excluded from the study. Permission to use
each instrument has been obtained and license costs
have been paid as necessary.
Neurocognition
Electroencephalography (EEG) The impact of gaming
on brain functional networks and changes in neuronal
dynamics can be revealed by an EEG during the execu-
tion of a visual working memory task. Resting-state EEG
will be collected to evaluate changes in spontaneous ac-
tivities in the brain for comparison with the resting-state
MRI. The EEG has been extensively utilised to assess the
effectiveness of daily cognitive exercises to improve sen-
sory information processing, from attention to working
memory processes, in people with schizophrenia. Its su-
perior temporal resolution is most apt in identifying
relevant markers in neuronal network dynamics that
underlie the observed improvement, that might help in
further identifying subsets of patients most likely to
benefit from cognitive exercises [49].
Resting-state fMRI In resting-state functional (rsfMRI)
and structural MRIs, the most often reported neurocog-
nition measurement for regions includes that of the nu-
cleus accumbens, amygdala, striatum, anterior cingulate
cortex, orbitofrontal cortex, and dorsolateral prefrontal
cortex [50], the dorsal lateral prefrontal cortex and the
anterior cingulate Testgyrus [51]. During the rsfMRI, the
subject will not perform any tasks while being scanned.
The rsfMRI is based on the principle that, even when
the brain is at rest, there are still low fluctuations of
neural activity. While the resting-state neural activity is
at a much lower rate than when the brain is active, it
can be used as a biomarker to study the underlying
neuronal networks.
Comparing pre- and post-training records will reveal
the impact of cognitive training with computerised exer-
cises on the neuronal networks underlying the physio-
logical basis of working memory ability. We will assess
how the training influences inter-areal functional and
structural (measured with MRI/Diffusion tensor imaging
[DTI]) connectivity and the quantitative indices of cor-
tical criticality and excitation/inhibition balance.
Data collection and follow-up
To avoid burdening the patients, data will be collected
in separate phases (see Table 1):
1) A preparatory data collection (estimated 45 min)
will be collected only once, at the beginning of the
study. It aims to collate the background information
of the participants to determine their capacity for
informed consent and any other potential factors
that might restrict participation in the intervention
(background information, IQ, medication dosage
[based on medical records], MMSE, CDS-C, SAS,
BARS, AIMS).
2) For the primary (verbal working memory) and
secondary outcomes (estimated 75 min) (cognitive
and social functioning, experience of pleasure, self-
efficacy, negative symptoms), the data will be col-
lected at three points in time: at baseline, after the
intervention (3-month follow up) and at a six-
month follow-up (6 months after baseline).
3) The EEG measures taken during the working
memory test will be collected at baseline and 3
months after baseline only (EEG 1 h; rsfMRI and
structural MRI, 45 min).
First, for the primary and secondary outcomes (cogni-
tive and social functioning, experience of pleasure, self-
efficacy, negative symptoms), the data will be collected
in paper format or digital format [5] by a trained psych-
ologist or RA.
Second, the EEG will be recorded during resting state
and a multi-objects visual working memory task
(VWM). The task, modified from our prior studies [52],
will be performed so that the neuronal mechanisms lim-
iting VWM performance and capacity can be identified
during the memory retention period. Subjects will attend
either hemifield, depending on the pre-stimulus cue, and
memorise a visual display containing one to six objects.
After the retention period, a second stimulus will appear,
and the subject will answer whether the stimulus pre-
sented in the second display matches part of the first
display or not. We will correlate both local and large-
scale neuronal dynamics with the task performance, both
in pre-training and post-training neuroimaging sessions.
Third, fMRI scans will be acquired using a Philips 3 T
MRI scanner. During scanning, a painless procedure, pa-
tients will rest on a table, which will be slid into a large
tunnel-shaped scanner. As there will be a constant
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drumming noise during scanning, earplugs or earphones
will be provided. During the examination, the patient will
be able to freely communicate with staff via an intercom.
Resting-state fMRI data will be acquired using T2-
weighted echo planar pulse sequence imaging (300 whole-
brain volumes were collected with slice thickness=4mm,
TE=30ms, TR= 2000ms, flip angle=90 degrees, spatial
resolution 3x3x4 mm isotropic voxels, transverse orienta-
tion, 32 slices fully covering the cerebral cortex and the
cerebellum, acquisition time = 10min). Structural MRIs
will be acquired with the MP-RAGE T1 sequence. A DTI
of the axonal tracts in cerebral white matter will be per-
formed with a protocol validated in the Human Connec-
tome Project. We will acquire a 15-min session of resting-
state data to obtain high-quality measurements of intrinsic
functional connectivity of BOLD signals (fMRI) [53] and
critical dynamics (fMRI) [54].
Data analysis
Cognitive and clinical outcomes
The demographic information and outcome measure-
ments of the participants in the three study groups will
be compared for similarities at baseline. Based on the
types of variables, Chi Square tests and analyses of vari-
ance (ANOVA) will be used for categorical and continu-
ous variables, respectively. Variables found significantly
different between study groups will be controlled in the
main analysis as covariates. The normality assumption of
the outcome scores will be tested (Kolmogorov-Simonov
tests). Outcome measures of non-normal distribution
will be transformed to normal in the main analysis.
In the main analysis, we will estimate and test efficacy
of interventions on the primary and secondary out-
comes. Based on the intention-to-treat principle, we will
first assess intervention effects on the primary outcome,













IQ (from medical records if available) X
Current medication dosage X
Computer use X
MMSE X
Calgary Depression Scale for Schizophrenia, CDS-C X
Simpson-Angus Rating Scale, SAS X
Barnes Akathisia Rating Scale, BARS X
Abnormal Movement Involuntary Scale, AIMS X
Primary and secondary outcomes
Letter-Number-Span-Test, LNST X X X
Trail Making Test, TMT X X X
Sustained Attention to Response Task, SART X X X
Spatial Span X X X
Wisconsin Card Sorting X X X
Brief Social Phobia Scale, BSPS X X X
Temporal Experience of Pleasure Scale, TEPS X X X
General Self-efficacy Scale, GSE X X X





Cognitive training with computerized exercises
(experiment group)
X
Entertainment video gaming (active control group) X
TAU (passive control group)
aConvenience sample; bRandomised subsample; cACP test planned but need to discontinue due to technological problems of the measure
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verbal working memory, by means of multilevel model-
ling analysis. A two-level model can be built with re-
peated time points at level 1, and patients at level 2.
Two indicator variables, G2 and G3, will be included in
the fixed part of the model to estimate and test mean
differences between the cognitive training group with
computerised exercises (G1) and the entertainment
gaming group (G2), as well as between G1 and the non-
gaming control group (G3). The baseline difference
between G2 and G3 can be tested using a Ward test,
based on the regression coefficient estimates of the two
indicators. For changes in the outcome over time, two
more indicators, variables T2 and T3, in contrast to the
baseline time point, T1, will be included in the fixed part
of the model to estimate changes from baseline to 3
months, and from baseline to 6 months. To assess the
effects of interventions over time, interaction terms be-
tween the treatment group indicators, G2 and G3, and
time indicators, T2 and T3, will be included in the fixed
part of the model. The significantly different demo-
graphics between groups identified in the first step of
the analysis and other possible confounders will be ad-
justed by including them in the main effect model. The
within-patient random effects of the outcome measure-
ments will naturally be taken into account by the level
two variance in the model. A pairwise comparison and
other hypotheses on the intervention effects can be
tested using a generalised Ward test with an adequate
degree of freedom from the modelling analysis. This
analysis approach has two main advantages: a statisti-
cally highly efficiency and taking missing data into ac-
count. The effects of interventions on other secondary
outcome measures, normally distributed and measured
at three time points, such as patients’ cognitive and so-
cial functioning, experience of pleasure, and self-efficacy,
will be analysed using the same model, but a separate
model for each outcome. A multilevel logistic model will
be used for outcomes in binary form, and multilevel
multinomial models will be used for ordinal or nominal
outcomes. For outcomes measured at two time points
only, such as neurocognitive outcomes, the model will
have only one time indicator with two interaction terms
to test the efficacy of cognitive training with compu-
terised exercises three months into the trial.
SPSS (the Statistical Package for the Social Sciences)
Missing Values will be used to identify the amount and
pattern of missing data. If missing values are few and
randomly allocated, the last observation carried forward
(LOCF) will be used to replace the missing data. If miss-
ing values are not randomly distributed, multiple imput-
ation approaches will be used. A sensitivity analysis will
be performed by comparing results from analysis data-
sets without missing data imputation and with
imputation.
In all tests, significant differences between groups will
be detected with a 95% confidence level, and P values of
< 0.05 will be considered significant. Statistical analyses
will be carried out with SAS System for Windows, ver-
sion 9.4 (SAS Institute Inc.) or R statistical software (R
Core Team, 2016).
Behavioural data analysis for neuroimaging measurement
Accuracy (%) and reaction times (ms [milliseconds]) will
be recorded for the cognitive tasks [55] and additional
signal detection indices will be calculated for the multi-
object visual working memory task. Change in
behavioural performance will be analysed for all three
groups using a multilevel regression/repeated measures
ANOVA, testing the task/group and by time interaction.
Within this framework, group differences in change will
be evaluated using contrast analyses.
EEG signals For EEG signals associated with specific de-
fined events, ERP data analysis will be conducted in
Curry 8 (Compumedics, Charlotte, NC, USA). Raw con-
tinuous EEG will be re-referenced to linked mastoids
and then bandpass filtered from 0.1 to 30 Hz. Eye blink
artifacts will be corrected by electrooculography (EOG)
regression method. Stimulus-locked epochs will be
extracted from − 200 ms before to 1000ms after the on-
sets of stimulus. Only trials with correct behavioural
responses will be included in the subsequent ERP ana-
lyses. Epochs of the same experimental condition will be
averaged to produce the ERP. The mean voltage between
− 200 and 0ms will be used for baseline correction. Elec-
trodes chosen for analyses cover the two hemispheres
and midline cortical regions. The six lateral electrodes
that cover two hemispheres include Fp1 and Fp2 for pre-
frontal regions, F3 and F4 for the frontal regions, C3 and
C4 for the central regions, T7 and T8 for the temporal
regions, P3 and P4 for the parietal regions, and PO3 and
PO4 for the parieto-occipital regions. The four elec-
trodes that cover the midline regions are Fz, Cz, Pz, and
POz. ERP components (P1, N1, N2 and P3), and their
corresponding time windows will be identified from the
grand averaged waveforms. The mean amplitude of each
ERP component will be calculated for further statistical
analysis.
MRI data analysis The outcomes will be analysed at
two points only (baseline and after 3 months). A time-
series statistical analysis will be carried out using FILM
(FMRIB S Improved Linear Model) with local autocor-
relation correction [52]. To increase the power to detect
group differences, to reduce the number of voxel-wise
statistical comparisons, and to avoid risk of bias for sub-
sequent analyses, the data from all subjects at both
points of data collection (54 sessions) will be pooled to
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identify functional regions of interest (ROIs) for each
task. Z-statistic images will be thresholded using a clus-
ter correction method to account for multiple compari-
sons, as determined by Z42.3, to provide a brain-wise
cluster significance threshold of p¼0.05.
Ethical issues
The WMA Declaration of Helsinki [56] and its ethical
principles for medical research involving human subjects
has guided our study design and protocol. The data col-
lection will be voluntary based; written informed consent
forms will be signed by patients. Prior to enrolment, par-
ticipants will be made aware of all potential risks and
benefits of participation (oral and written information).
All steps will be taken to avoid any harm to participants.
First, to minimise extra burden due to gaming interven-
tions, playing intensity will be set at a maximum of 5 h
per week, or it will be tailored to participants’ individual
needs. Second, we have chosen video games that are
purely fictional and do not include intentional violence.
Third, possible changes in a patient’s health status will
be continually monitored throughout the project.
Fourth, players in this study will play the game under
supervision only. Fifth, patients’ participation may be
biased toward those who are interested in gaming, which
will be taken into account in the conclusions. Any extra
costs to the patients as a result of participation (treat-
ment or travel costs, gaming licenses) will be covered.
Discussion
This study will be the first clinical trial in Hong Kong to
test the effectiveness of video gaming on improving cog-
nitive and neurocognitive functioning in people with
schizophrenia. The study will offer new insights into,
and characterization of, the impact of using video gam-
ing on patients’ health and well-being. The study will
also contribute towards the development of new ap-
proaches to patient care in mental health services in
Hong Kong. The results may also have implications for
other health conditions in which motivational problems
are related to health outcomes. The topic of the study is
justified by the need to develop more innovative and en-
gaging interventions for patients with schizophrenia
[13]. However, before making recommendations for pa-
tients and especially decision makers, we should have an
understanding of what the clinical outcomes of gaming
interventions on health and well-being are. If ICT (Infor-
mation and communications technology)-based inter-
ventions are to be taken as part of routine care without
a clear understanding of how they work, there is the
danger of using new interventions that may be non-
effective and costly. If successful, the findings of this
study will have the potential for remarkable societal and
clinical impact, particularly in relation to changing
treatment approaches and cultures in psychiatric ser-
vices. In the long run, the findings could inform whether
the gaming intervention could potentially reduce service
costs and if our interventions are effective. It might also
be possible that the study could result in a paradigm
shift for non-medicinal treatment for schizophrenia, as
this type of treatment is low-cost, easy to use and effect-
ive for cognitive symptoms of schizophrenia.
Study status
Patient recruitment is ongoing.
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